First in Human Study to Assess an Implant to Treat Severe Emphysema
NCT: NCT05854550 · COMPLETED
Brief Summary
The goal of this clinical trial is to test the feasibility of an implant for severe emphysema in up to 30 participants. The main questions it aims to answer are: Is it safe? Does it work? Participants who meet eligibility criteria will have up to two procedures 30 days apart, in which up to 3 implants will be placed in each lung during the procedure(s). Participants will be asked to return for follow-up visits at 30 days, and 3, 6, and 12 months after the procedure(s).
Frequently Asked Questions
What is First in Human Study to Assess an Implant to Treat Severe Emphysema?
First in Human Study to Assess an Implant to Treat Severe Emphysema is a clinical trial registered under NCT05854550. Current status: COMPLETED.
What is the status of NCT05854550?
The current status of NCT05854550 (First in Human Study to Assess an Implant to Treat Severe Emphysema) is: COMPLETED.
When did First in Human Study to Assess an Implant to Treat Severe Emphysema start?
First in Human Study to Assess an Implant to Treat Severe Emphysema started on 2023-05-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.